JP2022525706A5 - - Google Patents
Info
- Publication number
- JP2022525706A5 JP2022525706A5 JP2022504738A JP2022504738A JP2022525706A5 JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5 JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1903900.7A GB2582361A (en) | 2019-03-21 | 2019-03-21 | Adenosine receptor agonists |
| GB1903900.7 | 2019-03-21 | ||
| PCT/GB2020/050734 WO2020188288A1 (en) | 2019-03-21 | 2020-03-19 | Adenosine receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525706A JP2022525706A (ja) | 2022-05-18 |
| JPWO2020188288A5 JPWO2020188288A5 (https=) | 2023-03-27 |
| JP2022525706A5 true JP2022525706A5 (https=) | 2023-03-27 |
Family
ID=66381433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504738A Pending JP2022525706A (ja) | 2019-03-21 | 2020-03-19 | アデノシン受容体アゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220152077A1 (https=) |
| EP (1) | EP3941482A1 (https=) |
| JP (1) | JP2022525706A (https=) |
| GB (1) | GB2582361A (https=) |
| WO (1) | WO2020188288A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113082020A (zh) * | 2021-04-08 | 2021-07-09 | 徐州医科大学 | 一种腺苷受体激动剂的增强剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK62692D0 (https=) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| GB9930085D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| GB9930079D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| GB9930075D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
| CN103087133B (zh) * | 2004-05-26 | 2016-09-14 | 伊诺泰克制药公司 | 嘌呤衍生物作为腺苷a1受体激动剂及其用法 |
| WO2011011919A1 (zh) * | 2009-07-31 | 2011-02-03 | 新道生技股份有限公司 | 一种降血糖的组合物 |
| KR20130029049A (ko) * | 2010-03-26 | 2013-03-21 | 이노텍 파마슈티컬스 코포레이션 | 아데노신 화합물 및 이의 용도 |
| WO2017137528A1 (en) * | 2016-02-12 | 2017-08-17 | Charité - Universitätsmedizin Berlin | Adenosine a1 receptor agonist for use in treatment of status epilepticus |
-
2019
- 2019-03-21 GB GB1903900.7A patent/GB2582361A/en not_active Withdrawn
-
2020
- 2020-03-19 US US17/441,257 patent/US20220152077A1/en not_active Abandoned
- 2020-03-19 JP JP2022504738A patent/JP2022525706A/ja active Pending
- 2020-03-19 WO PCT/GB2020/050734 patent/WO2020188288A1/en not_active Ceased
- 2020-03-19 EP EP20715187.9A patent/EP3941482A1/en not_active Withdrawn